Products and Services
News & Events
Passed “Southern Science Park Emerging Technology Application Plan”
Develop CpG1018 successfully and provide samples to the potential customers.
Passed GMP follow-up inspection by TFDA
KriSan Biotech as a CDMO partner supplies Kg-scale of API to Atossa Genetic(NASDAQ: ATOS) from Pre-IND to Phase 2.
KriSan Biotech and OncoArendi Therapeutic (OAT) have entered into an agreement of API supply from Pre-IND to Phase 2.
Ms. Wang Yu Pei acts as President of KriSan Biotech Co., Ltd.